Atlas Trials

Platinum Refractory Epithelial Ovarian Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Platinum Refractory Epithelial Ovarian Cancer

RecordFirmDate
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor (NCT00543049)AGO Study Group2007-09-01

Track Platinum Refractory Epithelial Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.